Literature DB >> 24706871

Brain galanin system genes interact with life stresses in depression-related phenotypes.

Gabriella Juhasz1, Gabor Hullam, Nora Eszlari, Xenia Gonda, Peter Antal, Ian Muir Anderson, Tomas G M Hökfelt, J F William Deakin, Gyorgy Bagdy.   

Abstract

Galanin is a stress-inducible neuropeptide and cotransmitter in serotonin and norepinephrine neurons with a possible role in stress-related disorders. Here we report that variants in genes for galanin (GAL) and its receptors (GALR1, GALR2, GALR3), despite their disparate genomic loci, conferred increased risk of depression and anxiety in people who experienced childhood adversity or recent negative life events in a European white population cohort totaling 2,361 from Manchester, United Kingdom and Budapest, Hungary. Bayesian multivariate analysis revealed a greater relevance of galanin system genes in highly stressed subjects compared with subjects with moderate or low life stress. Using the same method, the effect of the galanin system genes was stronger than the effect of the well-studied 5-HTTLPR polymorphism in the serotonin transporter gene (SLC6A4). Conventional multivariate analysis using general linear models demonstrated that interaction of galanin system genes with life stressors explained more variance (1.7%, P = 0.005) than the life stress-only model. This effect replicated in independent analysis of the Manchester and Budapest subpopulations, and in males and females. The results suggest that the galanin pathway plays an important role in the pathogenesis of depression in humans by increasing the vulnerability to early and recent psychosocial stress. Correcting abnormal galanin function in depression could prove to be a novel target for drug development. The findings further emphasize the importance of modeling environmental interaction in finding new genes for depression.

Entities:  

Keywords:  galanin receptors; mood disorders; network-based analysis; neurogenesis; transmitter coexistence

Mesh:

Substances:

Year:  2014        PMID: 24706871      PMCID: PMC4000859          DOI: 10.1073/pnas.1403649111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  102 in total

Review 1.  Neuropeptides: opportunities for drug discovery.

Authors:  Tomas Hökfelt; Tamas Bartfai; Floyd Bloom
Journal:  Lancet Neurol       Date:  2003-08       Impact factor: 44.182

Review 2.  Neurotrophic effects of antidepressant drugs.

Authors:  Eero Castrén
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

3.  Galanin - a novel biologically active peptide from porcine intestine.

Authors:  K Tatemoto; A Rökaeus; H Jörnvall; T J McDonald; V Mutt
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

4.  The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat.

Authors:  T Brugha; P Bebbington; C Tennant; J Hurry
Journal:  Psychol Med       Date:  1985-02       Impact factor: 7.723

Review 5.  Interactions between NPY and CRF in the amygdala to regulate emotionality.

Authors:  Tammy J Sajdyk; Anantha Shekhar; Donald R Gehlert
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

6.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 7.  Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

Authors:  Andrew Holmes; Markus Heilig; Nadia M J Rupniak; Thomas Steckler; Guy Griebel
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG.

Authors:  Harald Murck; Katja Held; Marc Ziegenbein; Heike Künzel; Florian Holsboer; Axel Steiger
Journal:  Psychoneuroendocrinology       Date:  2004-10       Impact factor: 4.905

10.  Galanin acts as a neuroprotective factor to the hippocampus.

Authors:  Caroline R Elliott-Hunt; Barnaby Marsh; Andrea Bacon; Robert Pope; Penny Vanderplank; David Wynick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-23       Impact factor: 11.205

View more
  37 in total

1.  Fronto-temporal galanin modulates impulse control.

Authors:  F Messanvi; A Perkins; J du Hoffmann; Y Chudasama
Journal:  Psychopharmacology (Berl)       Date:  2019-11-08       Impact factor: 4.530

2.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

3.  Fibroblast growth factor 2 regulates activity and gene expression of human post-mitotic excitatory neurons.

Authors:  Shweta Gupta; Tanya M-Redmond; Fan Meng; Andrew Tidball; Huda Akil; Stanley Watson; Jack M Parent; Michael Uhler
Journal:  J Neurochem       Date:  2017-12-27       Impact factor: 5.372

4.  GAL3 receptor KO mice exhibit an anxiety-like phenotype.

Authors:  Susanne M Brunner; Aitak Farzi; Felix Locker; Barbara S Holub; Meinrad Drexel; Florian Reichmann; Andreas A Lang; Johannes A Mayr; Jorge J Vilches; Xavier Navarro; Roland Lang; Günther Sperk; Peter Holzer; Barbara Kofler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-29       Impact factor: 11.205

5.  Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis.

Authors:  K L Musliner; F Seifuddin; J A Judy; M Pirooznia; F S Goes; P P Zandi
Journal:  Psychol Med       Date:  2014-12-09       Impact factor: 7.723

6.  Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide.

Authors:  Swapnali Barde; Joelle Rüegg; Josée Prud'homme; Tomas J Ekström; Miklos Palkovits; Gustavo Turecki; Gyorgy Bagdy; Robert Ihnatko; Elvar Theodorsson; Gabriella Juhasz; Rochellys Diaz-Heijtz; Naguib Mechawar; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

7.  Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray.

Authors:  Peng Wang; Hui Li; Swapnali Barde; Ming-Dong Zhang; Jing Sun; Tong Wang; Pan Zhang; Hanjiang Luo; Yongjun Wang; Yutao Yang; Chuanyue Wang; Per Svenningsson; Elvar Theodorsson; Tomas G M Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

8.  Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence.

Authors:  Matthew Randesi; Orna Levran; Wim van den Brink; Peter Blanken; Jan M van Ree; Jurg Ott; Mary J Kreek
Journal:  Pharmacogenomics       Date:  2020-08-06       Impact factor: 2.533

Review 9.  Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.

Authors:  David Weinshenker; Philip V Holmes
Journal:  Brain Res       Date:  2015-11-20       Impact factor: 3.252

10.  Galanin mediates features of neural and behavioral stress resilience afforded by exercise.

Authors:  N R Sciolino; J M Smith; A M Stranahan; K G Freeman; G L Edwards; D Weinshenker; P V Holmes
Journal:  Neuropharmacology       Date:  2014-10-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.